Rexulti 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5W4Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,529
Award facts
- Contract value 100% obligated
- $27,528.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,528.69 to AmerisourceBergen Drug Corp for 30-count tablets of Rexulti 4 mg, a psychiatric medication used to treat schizophrenia and bipolar disorder. The award, issued on February 4, 2026, with completion targeted for February 5, 2026, was structured as a firm fixed-price contract with no set-aside designation, indicating open competitive procurement. This delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at up to $999,999,999 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., which also holds a $999,999,999 IDC with DLA Troop Support Medical extending through December 2031. Through these vehicles, AmerisourceBergen provides an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5W4Z?
SPE2DR26F5W4Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F5W4Z worth?
The government has obligated $27,529 on SPE2DR26F5W4Z.
Is contract SPE2DR26F5W4Z an order under another contract?
Yes. SPE2DR26F5W4Z is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5W4Z competed?
The extent of competition for SPE2DR26F5W4Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award